ST-segment elevation myocardial infarction (STEMI) is the most acute manifestation of
coronary artery disease and is associated with great morbidity and mortality. A complete …

The no-reflow phenomenon refers to the observation that when an organ is made ischemic
by occlusion of a large artery supplying it, restoration of patency in that artery does not …

Tissue regeneration is an active multiplex process involving the dynamic inflammatory
microenvironment. Under a normal physiological framework, inflammation is necessary for …

The no-reflow phenomenon following primary percutaneous coronary intervention (PPCI) in
acute ST-elevation myocardial infarction (STEMI) patients is a predictor of unfavorable …

Coronary microvascular dysfunction (CMD) is a common complication of ST-segment
elevation myocardial infarction (STEMI) and can lead to adverse cardiovascular events. This …

Background Acute total occlusion (ATO) is diagnosed in a substantial proportion of patients
with non-ST-elevation myocardial infarction (NSTEMI). We compared procedural outcomes …

目的: 探讨冠状动脉(冠脉) 内逆向应用重组人尿激酶原联合经皮冠脉介入治疗(PCI) 对ST
段抬高型心肌梗死(STEMI) 患者预后的影响. 方法: 选择心内科行急诊PCI 的STEMI 患者120 例 …

Objective: This study aimed to investigate the value of Gensini score and interleukin-1
receptor antagonist (IL-1ra) in assessing the condition and prognosis of patients with …

Objective ST-elevation myocardial infarction (STEMI) is a medical emergency demanding
immediate intervention, and primary percutaneous coronary intervention (pPCI) is the …

Introduction: Microvascular dysfunction in the setting of acute ST-segment elevation
myocardial infarction (STEMI) is an indicator of poor long-term prognosis. Prompt …